Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Immunotherapy

Tag: Immunotherapy

  • Biotechnopedia
  • DNA-Tales

Telomerase: The Quest For Reliable Cancer Therapeutics

DNA tales July 27, 2021July 27, 2021 1

Surupa Chakraborty, Amity University, Kolkata “The longer your telomeres, the better off you are”, remarkedElizabeth H. Blackburn, an eminent biologist and the Nobel Prize (2009) awardee for the remarkable discovery of how chromosomes are protected by telomeres and the enzyme telomerase. Insight into the fountain of youth: Telomeres are specialized minuscule molecular structures made from […]

Read More
  • BiotechToday
  • World

Plasmodium immunotherapy against Cancer

BioTech Today July 16, 2021July 16, 2021

Aqsa, Jamia Millia Islamia Cancer is a disease in which cells of the body grow abnormally and uncontrollably. Until now, there is still no permanent cure for cancer, but getting treatment for cancer might allow you to live for a certain period. Research for the cure of cancer has been underway for about 100 years […]

Read More
  • BiotechToday
  • World

An account of how far we have come to treating neuroblastoma

BioTech Today July 15, 2021July 14, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University Our cells divide for growth. Cancer starts when the growth of the cells gets out of control. Any cell can become cancerous at any stage and any age. Cancer development can begin even in fetal cells. What is Neuroblastoma? Neuroblastoma (NB) is a type of cancer that […]

Read More
  • BiotechToday
  • World

The recurrence of kidney cancer can be reduced

bioxone July 12, 2021July 11, 2021

Madhavi Bhatia, NIPER Guwahati Cancer is a disease that involves abnormal growth with the potential to spread to other parts of the body. There are various treatments available for cancer surgery, chemotherapy, immunotherapy, and radiotherapy. There is a higher risk of kidney cancer recurrence following surgery to remove tumours, but there is currently no treatment […]

Read More
  • BiotechToday
  • World

Cancer can be smart, but the immune system is smarter!

bioxone June 11, 2021June 11, 2021

Ananya Dutta, Bose Institute This is the aphorism of Memorial Sloan Kettering (MSK) Cancer Center, New York, USA.  At MSK it is believed that immunotherapy is one of the most promising treatments to treat, cure, and eventually prevent cancer. Immunotherapy cradled from MSK about more than a century ago. William Coley (1893), a surgeon at […]

Read More
  • BiotechToday
  • World

PARP inhibitors: One class of drugs for Multiple Forms of Cancer

bioxone June 10, 2021June 10, 2021 3

Sayak Banerjee, Amity University Kolkata Scientists have come over a class of drugs utilized in the treatment of breast and ovarian cancer which might be effective in other types of diseases with inadequate treatment alternatives. These are called PARP inhibitors which have the potential to kill cancer cells carrying a defect in the Polybromo 1(PBRM1) […]

Read More
  • BiotechToday
  • World

A prototype test to fight the deadly skin cancer melanoma

bioxone February 24, 2021February 23, 2021 1

Husna, Amity University Kolkata Melanoma is the most serious type of skin cancer that occurs when the pigment-producing cells that give color to the skin become cancerous. Once it spreads, the disease is known as metastatic melanoma which generally occurs during stage III or stage IV.  Metastatic melanoma is a very fatal disease and as […]

Read More
  • BiotechToday
  • World

Spliceosome-targeted Therapies in Triple-Negative Breast Cancer treatment

bioxone January 27, 2021January 27, 2021 1

Sayak Banerjee, Amity University Kolkata According to the scientists at Baylor College of Medicine, antiviral immune pathways in triple-negative breast cancers (TNBC) can be activated by therapeutics targeting RNA splicing along with the stimulation of tumour cell death. Around 10-20% of breast cancers are triple-negative, which signifies that they are negative not only for estrogen […]

Read More
  • BiotechToday
  • World

CAR T Cells: Scientists discover ON/OFF switches for cell immunotherapy

bioxone January 18, 2021January 18, 2021 4

Sayak Banerjee, Amity University Kolkata CAR T cells are genetically modified immune cells that have been engineered to recognize and invade tumor cells. The immune T cells are collected and modified in the laboratory to generate finely-tuned chimeric antigen receptor, which identifies a distinctive protein on the surface of the patient’s cancer cells. The modified […]

Read More
  • BiotechToday
  • World

HOW CANCER CELLS TO ESCAPE THE IMMUNE SYSTEM?

bioxone January 9, 2021January 9, 2021

PRAGYA SANTRA, AMITY UNIVERSITY KOLKATA The history of cancer research has always been a mystery in the result. Recently it was reported that cancer cells adapted themselves to grow and proliferate in an inflammatory environment. ENPP1, a readily accessible molecule found on the surface of cancer cells plays a major role in this mechanism.  Naturally, […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy